Surgery Partners, Inc.
Price Action
Technical Summary
WEAKENINGSurgery Partners, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 19), showing significant lag compared to the market leaders. Earnings growth of 7% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $13.97 | +4.44% | ABOVE |
| 50 SMA | $13.36 | +9.19% | ABOVE |
| 100 SMA | $14.37 | +1.56% | ABOVE |
| 150 SMA | $15.96 | -8.56% | BELOW |
| 200 SMA | $17.54 | -16.84% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SGRY in an uptrend right now?
SGRY has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is SGRY overbought or oversold?
SGRY's RSI (14) is 59. The stock is in neutral territory, neither overbought nor oversold.
Is SGRY outperforming the market?
SGRY has a Relative Strength (RS) Rating of 19 out of 99. SGRY is currently lagging the broader market.
Where is SGRY in its 52-week range?
SGRY is trading at $14.59, which is 60% of its 52-week high ($24.18) and 25% above its 52-week low ($11.41).
How volatile is SGRY?
SGRY has a Beta of 1.04 and 52-week volatility of 47%. It's more volatile than the S&P 500 - expect bigger swings.